Loading...
Loading...
By Sergio Vargas - Wed, 09/23/2026 - 07:00
Investing in Mexico's health innovation and clinical research drives productivity, economic growth, and better care, writes Sergio Vargas.
https://mexicobusiness.news/tag/clinical-trials
More Tech
By Sergio Arturo Lievano Madrigal - Fri, 09/18/2026 - 10:25
Anthropic confirms a Bay Area wet lab for physical biology experiments as it expands AI-driven drug research, while it stays out of clinical trials.
By Sergio Arturo Lievano Madrigal - Mon, 09/07/2026 - 08:13
Faster clinical trial approvals and over US$643 million in pharma investment are positioning Mexico as a nearshoring manufacturing hub.
By Sergio Arturo Lievano Madrigal - Thu, 08/27/2026 - 13:54
Moderna aims to raise US$2 billion in convertible notes to fund oncology growth and debt repayment, following a rally driven by melanoma vaccine data.
By Sergio Arturo Lievano Madrigal - Thu, 08/20/2026 - 15:14
This week: ISSSTE opens a new Tampico hospital, AI reshapes patient adherence and mental health, and Mexico debates its health insurance reform.
By Sergio Arturo Lievano Madrigal - Wed, 08/19/2026 - 12:04
Merck and Moderna's mRNA melanoma vaccine clears Phase 3, as Mexico speeds trial approvals to attract advanced oncology research investment.
By Sergio Arturo Lievano Madrigal - Thu, 08/13/2026 - 14:46
Complex disease burdens should be addressed by considering the entire patient journey rather than isolated interventions, says AbbVie’s Sergio Vargas.
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 16:31
This week, ISSSTE expands clinics, COFEPRIS advances trial reform, and AI reshapes oncology and digital health. This and more in the weekly roundup.
By Sergio Arturo Lievano Madrigal - Mon, 07/27/2026 - 17:06
COFEPRIS and CONBIOÉTICA briefed Mexico's clinical research sector on the General Health Law reform, aiming to speed reviews.
By Luis Alberto Velez - Mon, 07/27/2026 - 07:30
AI in precision oncology drives drug design, biomarker discovery, and smarter trials to reduce biological uncertainty, writes Luis Velez.
By MBN Staff - Wed, 07/15/2026 - 10:33
The World Health Organization (WHO) launches first Ebola antiviral trial testing Gilead's obeldesivir in the DRC and Uganda.









